Imagen 1 de 1
Foto genérica
Imagen 1 de 1
Foto genérica
Handbook of Targeted Cancer Therapy and Immunotherapy: Breast Cancer by Debasish Tripathy and Senthilkumar Damodaran (2022, Trade Paperback)
AlibrisBooks (478793)
98,9% de votos positivos
Precio:
USD88,10
Aproximadamente75,23 EUR
+ USD23,35 de envío
Devoluciones:
30 días para devoluciones. El comprador paga el envío de la devolución..
Estado:
New Trade paperback
- ¡Cómpralo ya!Handbook of Targeted Cancer Therapy and Immunotherapy: Breast Cancer: New
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Acerca de este artículo
Product Identifiers
PublisherLippincott Williams & Wilkins
ISBN-101975184564
ISBN-139781975184568
eBay Product ID (ePID)5057273922
Product Key Features
Number of Pages352 Pages
LanguageEnglish
Publication NameHandbook of Targeted Cancer Therapy and Immunotherapy: Breast Cancer
SubjectChemotherapy, Oncology
Publication Year2022
TypeTextbook
AuthorDebasish Tripathy, Senthilkumar Damodaran
Subject AreaMedical
FormatTrade Paperback
Dimensions
Item Weight0 Oz
Item Length7.1 in
Item Width4.2 in
Additional Product Features
Intended AudienceScholarly & Professional
Dewey Edition23
IllustratedYes
Dewey Decimal616.9944906
SynopsisDesigned for quick, everyday reference, Handbook of Targeted Cancer Therapy and Immunotherapy: Breast Cancer provides a practical overview of this rapidly advancing field. Comprehensive yet concise, this easy-access resource by Drs. Senthil Damodaran and Debu Tripathy of MD Anderson Cancer Center helps you filter and apply the most recent discoveries as they pertain to specific tumor types, actionable molecular targets, and clinical performance of approved or investigational targeted agents and combinations of agents., Designed for quick, everyday reference, Handbook of Targeted Cancer Therapy and Immunotherapy: Breast Cancer provides a practical overview of this rapidly advancing field. Comprehensive yet concise, this easy-access resource by Drs. Senthil Damodaran and Debu Tripathy of MD Anderson Cancer Center helps you filter and apply the most recent discoveries as they pertain to specific tumor types, actionable molecular targets, and clinical performance of approved or investigational targeted agents and combinations of agents. Covers breast cancer targets--Phase 1, 2, and 3 trials and preliminary results, as well as approved therapies. Includes sections on Molecular Targets and Pathways, and Targeted and Immunotherapy Agents. Contains a section on Molecular Diagnostics, Testing, and Interpretation, with essential content customized for breast cancer. Organizes information by tumor type, pathway, and drug name, so you can approach clinical challenges from any direction. Highlights FDA approvals throughout. Pocket-sized and color coded to help you find information quickly and easily. Enrich Your eBook Reading Experience Read directly on your preferred device(s), such as computer, tablet, or smartphone. Easily convert to audiobook, powering your content with natural language text-to-speech.
LC Classification NumberRC280.B8
